Latest Headlines
-
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
1/30/2024
Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in a shorter manufacturing time for Yescarta® (axicabtagene ciloleucel). With this approval, Kite’s median turnaround time (TAT) in the U.S. is anticipated to be reduced from 16 days to 14 days. Median TAT is defined as time from leukapheresis, when a patient’s T cells are collected, to product release; manufacturing is
-
AbbVie Announces $223 Million Investment For New Biologics Manufacturing Facility In Singapore
1/29/2024
AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network.
-
INTEPRHEX Puts Hot-Topic Science In 2024 Event Registration Now Open | Event Program Now Online
1/22/2024
The reimagined INTERPHEX Conference is designed to bring attendees together to solve their business challenges and to understand the science that is shaping their industries.
-
Cleanroom Leader AES Clean Technology Announces New Chief Revenue Officer
1/18/2024
A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).
-
AST To Exhibit Aseptic Filling Technologies At Advanced Therapies Week
12/27/2023
AST has over 50 years of experience designing, manufacturing, and servicing innovative, high quality and highly automated processing equipment. Beginning in 2006, AST leveraged our experience and close customer relationships to revolutionize the aseptic fill/finish industry with the launch of the ASEPTiCell® development.
- We Are Becoming Cencora PharmaLex 12/27/2023
-
AST Offers Aseptic Processing Solutions For Life Science Innovators
12/22/2023
The path to a successful life science startup is exciting, difficult, and unpredictable. Recent years have seen a volatile pattern emerge of challenge, change and innovation within the life sciences.
-
An As-Needed Approach To Aseptic Pharmaceutical Fill-Finish Change Parts
12/13/2023
Aseptic fill-finish professionals are continually looking to augment their approach to a market that continues to grow and reflect innovations happening around sterile parenteral treatments.
- CleanSpace Accelerates Cleanroom Design-Build Process For Life Science Manufacturers By Connecting Cleanrooms To Real Estate 11/30/2023
-
CPC Celebrates 10th Anniversary Of AseptiQuik® G Connectors
11/15/2023
Single-use technologies (SUT) have radically changed biopharmaceutical operations. Sterile single-use connectors are key to enabling this shift. CPC, the leader in the design and manufacture of single-use connection technologies for life sciences markets, introduced its genderless single-use AseptiQuik® G Connectors 10 years ago and continues to expand its aseptic connector portfolio.